Female urethral dilation

Bazi, Tony; Abou-Ghannam, Gael; Khauli, Raja B.

doi:10.1007/s00192-013-2055-5

Cited by 7 publications

(4 citation statements)

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This, despite a lack of scientific evidence supporting the long-term efficacy. There have been a handful of randomized controlled trials of varying strengths evaluating the success of urethral dilation, but none of these addressed FUSD specifically [ 16 ]. Instead, they were targeting recurrent urinary tract infections or non-specific lower urinary tract symptoms.…”

Section: Discussionmentioning

confidence: 99%

Female urethroplasty with dorsal onlay buccal mucosal graft: a single institution experience

et al. 2023

View full text Add to dashboard Cite

Purpose Female urethral stricture disease is frequently unrecognized or misdiagnosed, with controversy in the literature regarding the definition of strictures and approach to management. The purpose of this study is to report our institutional experience with female urethroplasty and add our experience to the growing body of research. Methods We performed a retrospective review of patients undergoing female urethroplasty with dorsal onlay BMG at the University of Colorado between March 2015 and December 2021 performed by two surgeons (BF and JO). The primary outcome measure was surgical success, defined as no stricture recurrence. The secondary outcome measure was the incidence of de novo urinary incontinence. Results 23 patients were included in our data analysis. The median duration of lower urinary tract symptoms prior to urethroplasty was 16 years. 87% had undergone previous dilations. At a median follow-up of 12.2 months (range 1–81 months), four patients required a secondary procedure for obstruction with an overall success rate of 83%. One patient developed de novo stress urinary incontinence and one patient developed urge urinary incontinence. Subgroup analysis was performed comparing the patients that developed stricture recurrence (N = 4) to those that did not (N = 19). Those with stricture recurrence had a longer duration of symptoms and more dilations prior to urethroplasty. Conclusion Female urethroplasty with BMG is effective at treating female urethral stricture disease, with excellent outcomes at over a year of follow-up and minimal risk of stress incontinence postoperatively.

show abstract

Section: Discussionmentioning

confidence: 99%

Female urethroplasty with dorsal onlay buccal mucosal graft: a single institution experience

et al. 2023

View full text Add to dashboard Cite

show abstract

“…It should be considered that there is a potential variant of this entity, of an acquired nature, in which fibrosis or stenosis forms secondary to repeated urinary tract infections in young girls. 5 Although the clinical management may be similar, these are 2 distinct entities and should be considered as such (eg, when further studies are indicated).…”

Section: Discussionmentioning

confidence: 99%

Congenital Meatal Urethral Stenosis in a Female Patient: A Case Report

Arredondo Montero,

Ayuso González,

Hernández Martín

et al. 2023

Int J Surg Pathol

View full text Add to dashboard Cite

We present the case of a 6-year-old girl who presented with alterations in the voiding stream. On physical examination, a very small urethral meatus was identified at the expense of a membrane. The renovesical ultrasound showed no alterations. An uroflowmetric study was performed, showing a bladder outlet obstruction pattern. The urethral meatus was calibrated and a ventral meatotomy was performed. The histological study of the resected membrane showed a transitional urethral mucosa with chronic focal inflammation and discrete hyperplasia. The patient evolved favorably, with resolution of the symptoms and no notable complications. This is, to the best of our knowledge, the first reported case with a histological study of a congenital meatal urethral stenosis. In the presence of lower urinary tract obstruction, this entity should be considered in the differential diagnosis. Surgical treatment is curative.

show abstract

“…In 2013, Bazi and co-workers supported Yoon’s statement and suggested that there is no justification for urethral dilation for the treatment of UPS, and that this procedure may do more harm than good. Urethral dilation is an invasive surgical procedure that causes irritative symptoms and is associated with various complications, including infections, incontinence and stricture development [16].…”

Section: Discussionmentioning

confidence: 99%

“…Many different treatment methods, including local corticosteroids, antibiotics, alpha-blockers, topical vaginal estrogen, female urethral dilation, local anesthetics, mucosal protecting agents, acupuncture, antidepressants, bladder training, and physical therapy, have been tested with various effects [5, 10, 13–16]. In previous studies, it is recommended that the therapeutic approach should be multimodal, and it is stated that “treatment at its best is by trial and error” [6, 10, 13].…”

Section: Introductionmentioning

confidence: 99%

Treatment of Urethral Pain Syndrome (UPS) in Sweden

et al. 2019

View full text Add to dashboard Cite

BackgroundUrethral Pain Syndrome (UPS) in women is a recurrent urethral pain without any proven infection or other obvious pathology. There are few studies on UPS, and evidence-based treatment is lacking. The primary aim was to study what treatments are used, and to compare the treatment tradition of UPS in Sweden in 2018, with what was used in 2006.MethodsA questionnaire on the treatment of women with UPS was sent to all public gynecology, urology, gynecologic oncology and venereology clinics, and one public general practice in each county in Sweden in 2018. Private practice clinics in gynecology responded to the survey in 2017. Comparisons were made with the same survey sent to gynecology and urology clinics in 2006.FindingsOf 137 invited clinics in 2018, 99 (72.3%) responded to the survey. Seventy-seven (77.8%) of them saw women with UPS and 79.2% (61/77) of these clinics treated the patients using 19 different treatment methods. Local corticosteroids and local estrogens were the methods most used. Treatments were similar in gynecology and urology clinics in 2006 and 2018, although strong corticosteroids had increased in use in the treatment regimens of 2018. More than half of the clinics used antibiotics.InterpretationSince there is no evidence-based treatment of UPS, a wide spectrum of treatments is used, and different specialties use different treatment strategies. Despite the lack of proven infection, a large number of clinics also treated the syndrome with antibiotics. There is thus a need for well-designed randomized controlled clinical trials to find evidence-based treatments of UPS.

show abstract

Female urethral dilation

Abstract: Conflicting results and diverse opinions have characterized the use of UD until present time. Professional societies are urged to attend to this issue, and to identify possible areas where UD could be potentially investigated.

Cited by 7 publications

References 73 publications

Female urethroplasty with dorsal onlay buccal mucosal graft: a single institution experience

Female urethroplasty with dorsal onlay buccal mucosal graft: a single institution experience

Congenital Meatal Urethral Stenosis in a Female Patient: A Case Report

Treatment of Urethral Pain Syndrome (UPS) in Sweden

Contact Info

Product

Resources

About